Ronald W. Clark - Concepedia

Author

Ronald W. Clark

Pfizer (United States)

Also Known As

R CLARK, R W Clark, R. Clark, R. W. Clark, R.W. Clark, RONALD CLARK, Ronald Clark, Ronald W Clark, Ronald W. Clark

108

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)

About

Ronald W. Clark is an author at Pfizer (United States) specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Health Sciences	5	5	633
3	Education	1	1	17
4	Engineering	1	1	35
5	Humanities	1	1	28

Ronald W. Clark

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol Margaret E. Brousseau, Ernst J. Schaefer, Megan L. Wolfe, New England Journal of Medicine	2004	774
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects Saswata Talukdar, Yingjiang Zhou, Dongmei Li, Cell Metabolism ObesityMetabolic SyndromeLong-acting Fgf21 MoleculeGrowth HormoneMetabolic Disorder	2016	477
Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein Ronald W. Clark, Tamara A. Sutfin, Roger B. Ruggeri, Arteriosclerosis Thrombosis and Vascular Biology	2004	371
Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules Xiayang Qiu, Anil Mistry, Mark Ammirati, Nature Structural & Molecular Biology Crystal StructureProteinlipid InteractionLong TunnelBiochemistryNatural Sciences	2007	270
Einstein: The Life and Times J. L. Heilbron, Ronald W. Clark The American Historical Review TemporalitySpecial Relativity	1972	269
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action Ronald W. Clark, Roger B. Ruggeri, David Cunningham, Journal of Lipid Research Transfer ProteinSignal TransductionLipid SynthesisBiochemistryOxysterol	2005	142
Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2) Kentaro Futatsugi, Daniel W. Kung, Suvi T. M. Orr, Journal of Medicinal Chemistry Combinatorial ChemistryLipid AnalysisMedicinal ChemistryBioorganic ChemistryLipid Synthesis	2015	80
Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors Shenping Liu, Anil Mistry, Jennifer M. Reynolds, Journal of Biological Chemistry	2012	73
Polymorphisms in the CETP gene and association with CETP mass and HDL levels John F. Thompson, Maruja E. Lira, L. Kathryn Durham, Atherosclerosis Hdl LevelsGeneticsGenetic EpidemiologyCetp GenePathology	2003	63
Mice deleted for GPAT3 have reduced GPAT activity in white adipose tissue and altered energy and cholesterol homeostasis in diet-induced obesity Jingsong Cao, Sylvie Perez, Bryan Goodwin, American Journal of Physiology-Endocrinology and Metabolism Cholesterol HomeostasisObesityMetabolic SyndromeTotal Gpat ActivityMetabolic State	2014	55

Page 1